<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02185716</url>
  </required_header>
  <id_info>
    <org_study_id>2013-414</org_study_id>
    <nct_id>NCT02185716</nct_id>
  </id_info>
  <brief_title>Transversus Abdominis Plane Block (TAP) for Laparoscopic Cholecystectomy Surgery</brief_title>
  <official_title>Comparison Of Ultrasound Guided Transversus Abdominis Plane Block (TAP) and Local Infiltration Analgesia During Laparoscopic Cholecystectomy Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duzce University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duzce University</source>
  <brief_summary>
    <textblock>
      Postoperative pain is a significant cause of increased morbidity in the perioperative period,
      leading to patient discomfort and greater hospital length of stay. Laparoscopic
      cholecystectomy associated with significant postoperative pain, a substantial component of
      which is derived from abdominal wall incisions. Ultrasound-guided TAP block increasingly has
      been used for providing pain relief following abdominal surgeries. We designed this study
      with the hypothesis that, administering TAP block with levobupivacaine in laparoscopic
      cholecystectomy provides superior analgesic effects than port-side infiltration.

      In this randomized and double-blind study, 75 patients who are in American Society of
      Anesthesiology (ASA) I-II risk group, between the ages of 20-60, and who will undergo
      elective laporoscopic cholecystectomy operation under general anesthesia will be accepted.
      The patients will be divided into three groups and they will be given postoperative pain
      treatment with patient-controlled analgesia device. In hours of postoperative 1, 2, 4, 8, 12,
      16 and 24,VAS I (superficial pain), VAS II (deep pain), postoperative total analgesic
      proportion, nausea, and vomiting will be recorded under evaluation Postoperative sedation
      score will be recorded (as conscious:0, asleep:1, deep sleep:2 ) in hours of postoperative 1,
      2, 4, 8, 12, 16 and 24.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain scores</measure>
    <time_frame>24 hours</time_frame>
    <description>VAS I (superficial pain), VAS II (deep pain) recorded in hours of postoperative 1, 2, 4, 8, 12, 16 and 24 h,</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative total analgesic consumption</measure>
    <time_frame>Postoperatively 24 h</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>side effects</measure>
    <time_frame>postoperatively 24 h</time_frame>
    <description>In hours of postoperative 1, 2, 4, 8, 12, 16 and 24 nausea, and vomiting will be recorded.Nausea (0=non-existent, 1=mild, 2 = severe) and vomiting (0=non-existent, 1=mild, 2 = severe) of the patients will be scored postoperatively on a 3-point scale.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Cholecystectomy, Laparoscopic</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>local infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group L (n=25) will be given total 30 ml 0.25 % levobupivacaine infiltration around trocar-site with injector in sterilized conditions without administering TAP block at the end of the operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Only routine general anesthesia will be applied</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group T (n=25) will be given bilateral total 30 ml 0.25 % levobupivacaine administering TAP block under the guidance of ultrasound at the preoperative period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine 0.25 %</intervention_name>
    <arm_group_label>TAP</arm_group_label>
    <other_name>chirocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine 0.5%</intervention_name>
    <arm_group_label>local infiltration</arm_group_label>
    <other_name>chirocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-II risk group,

          -  between the ages of 20-60,

          -  undergo elective laporoscopic cholecystectomy operation under general anesthesia

        Exclusion Criteria:

          -  allergy to anesthetic medication,

          -  coronary artery patients,

          -  obese patients,

          -  emergencies,

          -  pregnants,

          -  abdomen operation history

          -  heart block
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Duzce University Medical Faculty</name>
      <address>
        <city>Duzce</city>
        <zip>81160</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Wassef M, Lee DY, Levine JL, Ross RE, Guend H, Vandepitte C, Hadzic A, Teixeira J. Feasibility and analgesic efficacy of the transversus abdominis plane block after single-port laparoscopy in patients having bariatric surgery. J Pain Res. 2013 Nov 27;6:837-41. doi: 10.2147/JPR.S50561. eCollection 2013.</citation>
    <PMID>24348067</PMID>
  </results_reference>
  <results_reference>
    <citation>Keir A, Rhodes L, Kayal A, Khan OA. Does a transversus abdominis plane (TAP) local anaesthetic block improve pain control in patients undergoing laparoscopic cholecystectomy? A best evidence topic. Int J Surg. 2013;11(9):792-4. doi: 10.1016/j.ijsu.2013.05.039. Epub 2013 Jun 11. Review.</citation>
    <PMID>23770342</PMID>
  </results_reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2014</study_first_submitted>
  <study_first_submitted_qc>July 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2014</study_first_posted>
  <last_update_submitted>January 25, 2016</last_update_submitted>
  <last_update_submitted_qc>January 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Duzce University</investigator_affiliation>
    <investigator_full_name>gulbin sezen</investigator_full_name>
    <investigator_title>assistant of professor</investigator_title>
  </responsible_party>
  <keyword>Transversus abdominis plane block</keyword>
  <keyword>levobupivacaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

